CLINICAL TRIALS AND STUDIES

Biotechnology News Magazine has established a strong bond with the biotech industry. We don’t dare try to interpret the clinical trials we receive from companies. We leave that up to you! We’ll continue to provide you with the latest biotech news as it happens.

Galapagos and Gilead: Discontinue ISABELA Phase 3 Trials in IPF

February 10, 2021 Galapagos NV and Gilead Sciences decision to halt the ISABELA Phase 3 clinical studies with the investigational autotaxin inhibitor ziritaxestat in patients...

February 10, 2021

Biophytis Announces Start of Patient Recruitment in Brazil and the USA for Part 2 of the Phase 2-3 COVA Trial

Patient recruitment at most clinical centers in Brazil and the United States will begin for Part 2 of its COVA Study assessing Sarconeos (BIO101) as a potential treatment for acute respiratory failure associated with COVID-19.

February 3, 2021

1...54 5556Page 56 of 56

Biotechnology News Magazine

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

MGCLF – MGC Pharma’s CannEpil® Now Accessible to UK Patients on Named Patient Request Basis

CLINICAL TRIALS AND STUDIES

Galapagos and Gilead: Discontinue ISABELA Phase 3 Trials in IPF

Biophytis Announces Start of Patient Recruitment in Brazil and the USA for Part 2 of the Phase 2-3 COVA Trial